| Beverlycare Women's Health | |
|
1920 W Whittier Blvd Montebello CA 90640-4009 | |
| (323) 725-1519 | |
| Not Available |
| Full Name | Beverlycare Women's Health |
|---|---|
| Speciality | Clinic/Center |
| Location | 1920 W Whittier Blvd, Montebello, California |
| Authorized Official Name and Position | Corali Nakamatsu (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 3237255073 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Beverlycare Women's Health 1920 W Whittier Blvd Montebello CA 90640-4009 Ph: (323) 726-1400 | Beverlycare Women's Health 1920 W Whittier Blvd Montebello CA 90640-4009 Ph: (323) 725-1519 |
| NPI Number | 1114562287 |
|---|---|
| Provider Enumeration Date | 11/13/2019 |
| Last Update Date | 05/05/2020 |
| Medicare PECOS PAC ID | 9537416102 |
|---|---|
| Medicare Enrollment ID | O20200519002291 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.
News outlets offer consumer tips for using healthcare.gov and take a look at where things stand in terms of obtaining coverage as of Jan. 1.
An integrated approach that unifies psychosocial factors with neurobiology sheds light on chronic pain traits and their underlying brain networks, according to a study published August 20 in the open-access journal PLOS Biology by A. Vania Apkarian of Northwestern University Feinberg School of Medicine, and colleagues.
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.
According to preliminary results of a study in Africa, although circumcision offers men some protection from the AIDS virus, if they are already-infected, unless they let the penis heal completely they may put women at an even higher risk of contracting the virus.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114562287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | (* (Not Available)) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer.
News outlets offer consumer tips for using healthcare.gov and take a look at where things stand in terms of obtaining coverage as of Jan. 1.
An integrated approach that unifies psychosocial factors with neurobiology sheds light on chronic pain traits and their underlying brain networks, according to a study published August 20 in the open-access journal PLOS Biology by A. Vania Apkarian of Northwestern University Feinberg School of Medicine, and colleagues.
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.
According to preliminary results of a study in Africa, although circumcision offers men some protection from the AIDS virus, if they are already-infected, unless they let the penis heal completely they may put women at an even higher risk of contracting the virus.
› Verified 4 days ago
Md Health Network Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1336 W Whittier Blvd, Montebello, CA 90640 Phone: 323-726-2255 | |
Farmacia Montebello Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 833 W Whittier Blvd Ste C, Montebello, CA 90640 Phone: 323-888-8552 Fax: 323-694-2583 | |
Kincaids Nutrition Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 711 Newmark Mall, Montebello, CA 90640 Phone: 323-726-1947 Fax: 323-726-1948 | |
Sudha Govindarrajan Md A Professional Corp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 101 E Beverly Blvd Ste 302, Montebello, CA 90640 Phone: 323-728-8181 Fax: 323-724-9725 | |
Abdul M. Alaama, M.d., Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 101 E Beverly Blvd Ste 204, Montebello, CA 90640 Phone: 323-728-8009 Fax: 323-728-3855 | |
Beverly Care Medical Group, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 E Beverly Blvd Ste 303, Montebello, CA 90640 Phone: 323-837-5147 |